Florian Lasch

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 6

Top Topics

Anterior Cruciate Ligament Reconstruction

Top Venues

Pharmaceutical statistics

JMIR serious games

Open access journal of sports medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Florian Lasch, Lorenzo Guizzaro, Lukas Aguirre Dávila, Kirsten Müller-Vahl, Armin Koch
Potential impact of COVID-19 on ongoing clinical trials: a simulation study with the neurological Yale Global Tic Severity Scale based on the CANNA-TICS study. Pharmaceutical statistics 20 (3) (2021)
Verena Scheper, Melanie Schmidtheisler, Florian Lasch, Heiko von der Leyen, Armin Koch, Jana Schwieger, Andreas Büchner, Anke Lesinski-Schiedat, Thomas Lenarz
Randomized placebo-controlled clinical trial investigating the effect of antioxidants and a vasodilator on overall safety and residual hearing preservation in cochlear implant patients. Trials 21 (1) (2020)
Hauke Horstmann, Pascal Medico, Florian Lasch, Werner Krutsch, Thomas Sanjay Weber-Spickschen
Simplified Measurement of Maximum Strength After Knee Surgery: Application-Based Knee-Training Device Compared to Isokinetic Testing. Open access journal of sports medicine 11 (2020)
Jan-Dierk Clausen, Niclas Nahen, Hauke Horstmann, Florian Lasch, Werner Krutsch, Christian Krettek, Thomas Sanjay Weber-Spickschen
Improving Maximal Strength in the Initial Postoperative Phase After Anterior Cruciate Ligament Reconstruction Surgery: Randomized Controlled Trial of an App-Based Serious Gaming Approach. JMIR serious games 8 (1) (2020)
Sebastian Häckl, Armin Koch, Florian Lasch
Empirical evaluation of the implementation of the EMA guideline on missing data in confirmatory clinical trials: Specification of mixed models for longitudinal data in study protocols. Pharmaceutical statistics 18 (6) (2019)
Florian Lasch, Kristina Weber, Armin Koch
Commentary: On the levels of patient selection in registry-based randomized controlled trials. Trials 20 (1) (2019)